Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of type 2 diabetic patients

Diabetologia

Volumn 47, Issue 5, 2004, Pages 917-925

  Debard, C ^a   Laville, M ^a,b   Berbe, V ^a   Loizon, E ^a   Guillet, C ^c   Morio Liondore, B ^c   Boirie, Y ^c   Vidal, H ^a  

^a UNIVERSITÉ LYON 1   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c Laboratory of Human Nutrition   (France)

Author keywords

Acetyl CoA carboxylase; Adiponectin receptors; Fatty acid oxidation; Hyperinsulinaemic clamp; PGC1 a; Real time PCR

Indexed keywords

ACETYL COENZYME A; ADIPONECTIN; CARBOXYLASE; CARNITINE PALMITOYLTRANSFERASE; ENZYME; FATTY ACID; INSULIN; ISOPROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PYRUVATE DEHYDROGENASE; RECEPTOR;

ADULT; ARTICLE; CLAMP; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID OXIDATION; FEMALE; GENE EXPRESSION; GENETIC CODE; GLUCOSE BLOOD LEVEL; HEALTH STATUS; HUMAN; HUMAN TISSUE; HYPERINSULINEMIA; INSULIN RESISTANCE; LEAN BODY WEIGHT; MALE; MUSCLE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; TIME;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FATTY ACIDS; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; OXIDATION-REDUCTION; REFERENCE VALUES;

EID: 2942622680     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1394-7     Document Type: Article

References (37)

1. Kelley DE, Mandarino LJ (2000) Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49:677-683
2. Kelley DE, Simoneau JA (1994) Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 94:2349-2356
3. Dagenais GR, Tancredi RG, Zierler KL (1976) Free fatty acid oxidation by forearm muscle at rest, and evidence for an intramuscular lipid pool in the human forearm. J Clin Invest 58:421-431
4. Blaak EE, Wagenmakers AJ, Glatz JF et al. (2000) Plasma FFA utilization and fatty acid-binding protein content are diminished in Type 2 diabetic muscle. Am J Physiol Endocrinol Metab 279:E146-E154
5. Blaak EE, van Aggel-Leijssen DP, Wagenmakers AJ, Saris WH, van Baak MA (2000) Impaired oxidation of plasma-derived fatty acids in Type 2 diabetic subjects during moderate-intensity exercise. Diabetes 49:2102-2107
6. McGarry JD (2002) Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of Type 2 diabetes. Diabetes 51:7-18
7. Hegarty BD, Furler SM, Ye J, Cooney GJ, Kraegen EW (2003) The role of intramuscular lipid in insulin resistance. Acta Physiol Scand 178:373-383
8. Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106:171-176
9. Kelley DE, He J, Menshikova EV, Ritov VB (2002) Dysfunction of mitochondria in human skeletal muscle in Type 2 diabetes. Diabetes 51:2944-2950
10. Patti ME, Butte AJ, Crunkhorn S et al. (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 100:8466-8471
11. Mootha VK, Lindgren CM, Eriksson KF et al. (2003) PGC-1 alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267-273
12. Petersen KF, Befroy D, Dufour S et al. (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300:1140-1142
13. Simoneau JA, Veerkamp JH, Turcotte LP, Kelley DE (1999) Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J 13:2051-2060
14. Fruebis J, Tsao TS, Javorschi S et al. (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 98:2005-2010
15. Tomas E, Tsao TS, Saha AK et al. (2002) Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci USA 99:16309-16313
16. Berg AH, Combs TP, Scherer PE (2002) ACRP30/ adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13:84-89
17. I7. Yamauchi T, Kamon J, Ito Y et al. (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762-769
18. Laville M, Auboeuf D, Khalfallah Y, Vega N, Riou JP, Vidal H (1996) Acute regulation by insulin of phosphatidylinositol-3-kinase, Rad, Glut 4, and lipoprotein lipase mRNA levels in human muscle. J Clin Invest 98:43-49
19. Ducluzeau PH, Perretti N, Laville M et al. (2001) Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in Type 2 diabetes. Diabetes 50:1134-1142
20. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 162:156-159
21. Rome S, Clement K, Rabasa-Lhoret R et al. (2003) Microarray profiling of human skeletal muscle reveals that insulin regulates approximately 800 genes during a hyperinsulinemic clamp. J Biol Chem 278:18063-18068
22. Vestergaard H, Bjorbaek C, Hansen T, Larsen FS, Granner DK, Pedersen O (1995) Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients. J Clin Invest 96:2639-2645
23. Binnert C, Koistinen HA, Martin G et al. (2000) Fatty acid transport protein-1 mRNA expression in skeletal muscle and in adipose tissue in humans. Am J Physiol Endocrinol Metab 279:E1072-E1079
24. Kerner J, Hoppel C (2000) Fatty acid import into mitochondria. Biochim Biophys Acta 1486:1-17
25. Lee CH, Olson P, Evans RM (2003) Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144:2201-2207
26. Knutti D, Kralli A (2001) PGC-1, a versatile coactivator. Trends Endocrinol Metab 12:360-365
27. Bach D, Pich S, Soriano FX et al. (2003) Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem 278:17190-17197
28. Bavenholm PN, Kuhl J, Pigon J, Saha AK, Ruderman NB, Efendic S (2003) Insulin resistance in Type 2 diabetes: association with truncal obesity, impaired fitness, and atypical malonyl coenzyme A regulation. J Clin Endocrinol Metab 88:82-87
29. Bavenholm PN, Pigon J, Saha AK, Ruderman NB, Efendic S (2000) Fatty acid oxidation and the regulation of malonyl-CoA in human muscle. Diabetes 49:1078-1083
30. Rasmussen BB, Holmback UC, Volpi E, Morio-Liondore B, Paddon-Jones D, Wolfe RR (2002) Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle. J Clin Invest 110:1687-1693
31. Yamauchi T, Kamon J, Waki H et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946
32. Glatz JF, Bonen A, Luiken JJ (2002) Exercise and insulin increase muscle fatty acid uptake by recruiting putative fatty acid transporters to the sarcolemma. Curr Opin Clin Nutr Metab Care 5:365-370
33. Dyck DJ, Steinberg G, Bonen A (2001) Insulin increases FA uptake and esterification but reduces lipid utilization in isolated contracting muscle. Am J Physiol Endocrinol Metab 281:E600-E607
34. Stump CS, Short KR, Bigelow ML, Schimke JM, Nair KS (2003) Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci USA 100:7996-8001
35. Sugden MC, Bulmer K, Holness MJ (2001) Fuel-sensing mechanisms integrating lipid and carbohydrate utilization. Biochem Soc Trans 29:272-278
36. Andersen PH, Lund S, Vestergaard H, Junker S, Kahn BB, Eedersen O (1993) Expression of the major insulin regulatable glucose transporter (GLUT4) in skeletal muscle of noninsulin-dependent diabetic patients and healthy subjects before and after insulin infusion. J Clin Endocrinol Metab 77:27-32
37. Pendergrass M, Koval J, Vogt C et al. (1998) Insulin-induced hexokinase II expression is reduced in obesity and NIDDM. Diabetes 47:387-389